Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
This report contains market size and forecasts of Pneumococcal Bacteria Vaccine in global, including the following market information:
Global Pneumococcal Bacteria Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pneumococcal Bacteria Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pneumococcal Bacteria Vaccine companies in 2021 (%)
The global Pneumococcal Bacteria Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PPSV 23 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pneumococcal Bacteria Vaccine include Merck, Sanofi, Sinopharm, Pfizer, Walvax and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Bacteria Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumococcal Bacteria Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pneumococcal Bacteria Vaccine Market Segment Percentages, by Type, 2021 (%)
PPSV 23
PCV 13
PCV 10
Global Pneumococcal Bacteria Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pneumococcal Bacteria Vaccine Market Segment Percentages, by Application, 2021 (%)
Infant
Children
Adult
Global Pneumococcal Bacteria Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pneumococcal Bacteria Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumococcal Bacteria Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pneumococcal Bacteria Vaccine revenues share in global market, 2021 (%)
Key companies Pneumococcal Bacteria Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pneumococcal Bacteria Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi
Sinopharm
Pfizer
Walvax
GSK